VIM and non-small cell lung carcinoma: Using transcriptome data from 104 cases of advanced stage NSCLC profiled as part of the Cancer Genome Atlas (TCGA) [8], a gene set analysis (GSA) was performed to reveal biological categories for genes significantly enriched in relation to markers of EMT progression (vimentin vs. E-cadherin expression) (Figures 1A and 1B, respectively).